Inhibition of cervical cancer cell growth invitro and invivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6and E7oncogenes

Antiviral Research

Volumn 98, Issue 2, 2013, Pages 305-313

  Zhou, Jiansong ^a,c   Li, Baohua ^b,d   Peng, Chanjuan ^a,c   Wang, Fenfen ^b,d   Fu, Zhiqin ^a   Zhou, Caiyun ^a   Hong, Die ^b,d   Ye, Feng ^a   Lü, Weiguo ^a,b,d   Xie, Xing ^a,b,d  

^a Women's Reproductive Health Laboratory of Zhejiang Province   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c ZHEJIANG CANCER HOSPITAL   (China)

^d ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cervical cancer; HPV; Lentivirus; Monoclone; Promoter

Indexed keywords

LENTIVIRUS VECTOR; PROTEIN E6; PROTEIN E7; PROTEIN P16; PROTEIN P53; SHORT HAIRPIN RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL ASSAY; CELL INVASION; CELL SELECTION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL TIME; UTERINE CERVIX CANCER;

ANIMALIA; HUMAN PAPILLOMAVIRUS; LENTIVIRUS; MUS; MUS MUSCULUS;

EID: 84875997721     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2013.03.010     Document Type: Article

References (68)

1. Chang, J.T., Kuo, T.F., Chen, Y.J., Chiu, C.C., Lu, Y.C., Li, H.F., Shen, C.R., Cheng, A.J., 2010. Highly potent and specific siRNAs against E6orE7genes ofHPV16- or HPV18-infected cervical cancers.Cancer Gene Ther.17, 827-836.
2. Chang J.T., Kuo T.F., Chen Y.J., Chiu C.C., Lu Y.C., Li H.F., Shen C.R., Cheng A.J. Highly potent and specific siRNAs against E6 or E7 genes of HPV16- or HPV18-infected cervical cancers. Cancer Gene Ther. 2010, 17:827-836.
3. Check, E., 2005.Pioneering HIV treatment would use interference and gene therapy. Nature 437, 601.
4. Check E. Pioneering HIV treatment would use interference and gene therapy. Nature 2005, 437:601.
5. Courtete, J., Sibler, A.P., Zeder-Lutz, G., Dalkara, D., Oulad-Abdelghani, M., Zuber, G., Weiss, E., 2007.Suppression ofcervical carcinoma cell growth by intracytoplasmic codelivery of anti-oncoprotein E6antibody and small interfering RNA. Mol.Cancer Ther.6, 1728-1735.
6. Courtete J., Sibler A.P., Zeder-Lutz G., Dalkara D., Oulad-Abdelghani M., Zuber G., Weiss E. Suppression of cervical carcinoma cell growth by intracytoplasmic codelivery of anti-oncoprotein E6 antibody and small interfering RNA. Mol. Cancer Ther. 2007, 6:1728-1735.
7. DeFilippis, R.A., Goodwin, E.C., Wu, L., DiMaio, D., 2003.Endogenous human papillomavirus E6 and E7proteins differentially regulate proliferation, senescence, and apoptosis inHeLa cervical carcinoma cells.J.Virol.77, 1551-1563.
8. DeFilippis R.A., Goodwin E.C., Wu L., DiMaio D. Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells. J. Virol. 2003, 77:1551-1563.
9. Fehrmann, F., Laimins, L.A., 2003.Human papillomaviruses:targeting differentiating epithelial cells for malignant transformation.Oncogene 22, 5201-5207.
10. Fehrmann F., Laimins L.A. Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation. Oncogene 2003, 22:5201-5207.
11. Gu, W., Putral, L., Hengst, K., Minto, K., Saunders, N.A., Leggatt, G., McMillan, N.A., 2006. Inhibition ofcervical cancer cell growth invitro and invivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7oncogenes.Cancer Gene Ther.13, 1023-1032.
12. Gu W., Putral L., Hengst K., Minto K., Saunders N.A., Leggatt G., McMillan N.A. Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes. Cancer Gene Ther. 2006, 13:1023-1032.
13. Hong, D., Ye, F., Chen, H., Lü, W., Cheng, Q., Hu, Y., Xie, X., 2008.Distribution of human papillomavirus genotypes inthe patients with cervical carcinoma and its precursors inZhejiang Province China.Int.J.Gynecol.Cancer 18, 104-109.
14. Hong D., Ye F., Chen H., Lü W., Cheng Q., Hu Y., Xie X. Distribution of human papillomavirus genotypes in the patients with cervical carcinoma and its precursors in Zhejiang Province China. Int. J. Gynecol. Cancer 2008, 18:104-109.
15. Hong, D., Lu, W., Ye, F.Hu.Y., Xie, X., 2009.Gene silencing ofHPV16 E6/E7 induced by promoter-targeting siRNA inSiHa cells.Br.J.Cancer 101, 1798-1804.
16. Hong D., Lu W., Ye F.Hu.Y., Xie X. Gene silencing of HPV16 E6/E7 induced by promoter-targeting siRNA in SiHa cells. Br. J. Cancer 2009, 101:1798-1804.
17. Humeau, L.M., Binder, G.K., Lu, X., Slepushkin, V., Merling, R., Echeagaray, P., Pereira, M., Slepushkina, T., Barnett, S., Dropulic, L.K., Carroll, R., Levine, B.L., June, C.H., Dropulic, B., 2004.Efficientlentiviral vector-mediated control ofHIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral load.Mol.Ther.9, 902-913.
18. Humeau L.M., Binder G.K., Lu X., Slepushkin V., Merling R., Echeagaray P., Pereira M., Slepushkina T., Barnett S., Dropulic L.K., Carroll R., Levine B.L., June C.H., Dropulic B. Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral load. Mol. Ther. 2004, 9:902-913.
19. Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E., Forman, D., 2011.Global cancer statistics. CACancer J.Clin.61, 69-90.
20. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
21. Jones, L., Ratcliff, F., Baulcombe, D.C., 2001.RNA-directed transcriptional gene silencing in plants can beinherited independently ofthe RNA trigger and requires Met1 for maintenance.Curr.Biol.11, 747-757.
22. Jones L., Ratcliff F., Baulcombe D.C. RNA-directed transcriptional gene silencing in plants can be inherited independently of the RNA trigger and requires Met1 for maintenance. Curr. Biol. 2001, 11:747-757.
23. Jonson, A.L., Rogers, L.M., Ramakrishnan, S., Downs Jr., L.S., 2008.Gene silencing with siRNA targeting E6/E7 asatherapeutic intervention inamouse model of cervical cancer. Gynecol.Oncol.111, 356-364.
24. Jonson A.L., Rogers L.M., Ramakrishnan S., Downs L.S. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer. Gynecol. Oncol. 2008, 111:356-364.
25. Karwacz, K., Mukherjee, S., Apolonia, L., Blundell, M.P., Bouma, G., Escors, D., Collins, M.K., Thrasher, A.J., 2009.Nonintegrating lentivector vaccines stimulate prolonged T-cell and antibody responses and are effective intumor therapy.J. Virol. 83, 3094-3103.
26. Karwacz K., Mukherjee S., Apolonia L., Blundell M.P., Bouma G., Escors D., Collins M.K., Thrasher A.J. Nonintegrating lentivector vaccines stimulate prolonged T-cell and antibody responses and are effective in tumor therapy. J. Virol. 2009, 83:3094-3103.
27. Kohn, D.B., Sadelain, M., Glorioso, J.C., 2003.Occurrence ofleukaemia following gene therapy of X-linked SCID.Nat.Rev.Cancer 3, 477-488.
28. Kohn D.B., Sadelain M., Glorioso J.C. Occurrence of leukaemia following gene therapy of X-linked SCID. Nat. Rev. Cancer 2003, 3:477-488.
29. Lewinski, M.K., Bisgrove, D., Shinn, P., Chen, H., Hoffmann, C., Hannenhalli, S., Verdin, E., Berry, C.C., Ecker, J.R., Bushman, F.D., 2005.Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. J.Virol.79, 6610-6619.
30. Lewinski M.K., Bisgrove D., Shinn P., Chen H., Hoffmann C., Hannenhalli S., Verdin E., Berry C.C., Ecker J.R., Bushman F.D. Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. J. Virol. 2005, 79:6610-6619.
31. Liu, W.L., Green, N., Seymour, L.W., Stevenson, M., 2009.Paclitaxel combined with siRNA targeting HPV16 oncogenes improves cytotoxicity for cervical carcinoma. Cancer Gene Ther.16, 764-775.
32. Liu W.L., Green N., Seymour L.W., Stevenson M. Paclitaxel combined with siRNA targeting HPV16 oncogenes improves cytotoxicity for cervical carcinoma. Cancer Gene Ther. 2009, 16:764-775.
33. Mette, M.F., Aufsatz, W., van der Winden, J., Matzke, M.A., Matzke, A.J., 2000. Transcriptional silencing and promoter methylation triggered bydouble- stranded RNA. EMBO J.19, 5194-5201.
34. Mette M.F., Aufsatz W., van der Winden J., Matzke M.A., Matzke A.J. Transcriptional silencing and promoter methylation triggered by double-stranded RNA. EMBO J. 2000, 19:5194-5201.
35. Moody, C.A., Laimins, L.A., 2010.Human papillomavirus oncoproteins:pathways to transformation. Nat.Rev.Cancer 10, 550-560.
36. Moody C.A., Laimins L.A. Human papillomavirus oncoproteins: pathways to transformation. Nat. Rev. Cancer 2010, 10:550-560.
37. Morris, K.V., Chan, S.W., Jacobsen, S.E., Looney, D.J., 2004.Small interfering RNA- induced transcriptional gene silencing inhuman cells.Science 305, 1289-1292.
38. Morris K.V., Chan S.W., Jacobsen S.E., Looney D.J. Small interfering RNA-induced transcriptional gene silencing in human cells. Science 2004, 305:1289-1292.
39. Munger, K., Baldwin, A., Edwards, K.M., Hayakawa, H., Nguyen, C.L., Owens, M., Grace, M., Huh, K., 2004.Mechanisms ofhuman papillomavirus-induced oncogenesis. J.Virol.78, 11451-11460.
40. Munger K., Baldwin A., Edwards K.M., Hayakawa H., Nguyen C.L., Owens M., Grace M., Huh K. Mechanisms of human papillomavirus-induced oncogenesis. J. Virol. 2004, 78:11451-11460.
41. Muñoz, N., Bosch, F.X., deSanjosé, S., Herrero, R., Castellsagué, X., Shah, K.V., Snijders, P.J., Meijer, C.J., 2003.International Agency for Research onCancer Multicenter Cervical Cancer Study Group.Epidemiologic classificationofhuman papillomavirus types associated with cervical cancer.N.Engl.J.Med.348, 518-527.
42. Muñoz N., Bosch F.X., de Sanjosé S., Herrero R., Castellsagué X., Shah K.V., Snijders P.J., Meijer C.J. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 2003, 348:518-527.
43. Negri, D.R., Bona, R., Michelini, Z., Leone, P., Macchia, I., Klotman, M.E., Salvatore, M., Cara, A., 2010.Transduction ofhuman antigen-presenting cells with integrase- defective lentiviral vector enables functional expansion ofprimed antigen- specific CD8(+)Tcells.Hum.Gene Ther.21, 1029-1035.
44. Negri D.R., Bona R., Michelini Z., Leone P., Macchia I., Klotman M.E., Salvatore M., Cara A. Transduction of human antigen-presenting cells with integrase-defective lentiviral vector enables functional expansion of primed antigen-specific CD8(+) T cells. Hum. Gene Ther. 2010, 21:1029-1035.
45. Parkin, D.M., Bray, F., Ferlay, J., Pisani, P., 2005.Global cancer statistics, 2002.CA Cancer J. Clin.55, 74-108.
46. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55:74-108.
47. Quinn, M.A., Benedet, J.L., Odicino, F., Maisonneuve, P., Beller, U., Creasman, W.T., Heintz, A.P., Ngan, H.Y., Pecorelli, S., 2006.Carcinoma ofthe cervix uteri.FIGO 26th Annual Report on the Results ofTreatment inGynecological Cancer.Int.J. Gynaecol. Obstet.95(Suppl.1), S43-S103.
48. Quinn M.A., Benedet J.L., Odicino F., Maisonneuve P., Beller U., Creasman W.T., Heintz A.P., Ngan H.Y., Pecorelli S. Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int. J. Gynaecol. Obstet. 2006, 95(Suppl. 1):S43-S103.
49. Richards, E.J., 2006.Inherited epigenetic variation -revisiting soft inheritance.Nat. Rev. Genet.7, 395-401.
50. Richards E.J. Inherited epigenetic variation - revisiting soft inheritance. Nat. Rev. Genet. 2006, 7:395-401.
51. Scherr, M., Eder, M., 2002.Gene transfer into hematopoietic stem cells using lentiviral vectors. Curr.Gene Ther.2, 45-55.
52. Scherr M., Eder M. Gene transfer into hematopoietic stem cells using lentiviral vectors. Curr. Gene Ther. 2002, 2:45-55.
53. Smotkin, D., Wettstein, F.O., 1986.Transcription ofhuman papillomavirus type 16 early genes inacervical cancer and acancer-derived cell line and identification of the E7protein.Proc.Natl.Acad.Sci.USA 83, 4680-4684.
54. Smotkin D., Wettstein F.O. Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc. Natl. Acad. Sci. USA 1986, 83:4680-4684.
55. Sunaga, N., Miyajima, K., Suzuki, M., Sato, M., White, M.A., Ramirez, R.D., Shay, J.W., Gazdar, A.F., Minna, J.D., 2004.Different roles for caveolin-1 inthe development of non-small cell lung cancer versus small cell lung cancer.Cancer Res.64, 4277-4285.
56. Sunaga N., Miyajima K., Suzuki M., Sato M., White M.A., Ramirez R.D., Shay J.W., Gazdar A.F., Minna J.D. Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer. Cancer Res. 2004, 64:4277-4285.
57. Ting, A.H., Schuebel, K.E., Herman, J.G., Baylin, S.B., 2005.Short double-stranded RNA induces transcriptional gene silencing in human cancer cells inthe absence of DNA methylation.Nat.Genet.37, 906-910.
58. Ting A.H., Schuebel K.E., Herman J.G., Baylin S.B. Short double-stranded RNA induces transcriptional gene silencing in human cancer cells in the absence of DNA methylation. Nat. Genet. 2005, 37:906-910.
59. Yamato, K., Yamada, T., Kizaki, M., Ui-Tei, K., Natori, Y., Fujino, M., Nishihara, T., Ikeda, Y., Nasu, Y., Saigo, K., Yoshinouchi, M., 2008.New highly potent and specific E6and E7siRNAs for treatment ofHPV16 positive cervical cancer. Cancer Gene Ther.15, 140-153.
60. Yamato K., Yamada T., Kizaki M., Ui-Tei K., Natori Y., Fujino M., Nishihara T., Ikeda Y., Nasu Y., Saigo K., Yoshinouchi M. New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer. Cancer Gene Ther. 2008, 15:140-153.
61. Yáñez-Muñoz, R.J., Balaggan, K.S., MacNeil, A., Howe, S.J., Schmidt, M., Smith, A.J., Buch, P., MacLaren, R.E., Anderson, P.N., Barker, S.E., Duran, Y., Bartholomae, C., von Kalle, C., Heckenlively, J.R., Kinnon, C., Ali, R.R., Thrasher, A.J., 2006.Effective gene therapy with nonintegrating lentiviral vectors.Nat.Med.12, 348-353.
62. Yáñez-Muñoz R.J., Balaggan K.S., MacNeil A., Howe S.J., Schmidt M., Smith A.J., Buch P., MacLaren R.E., Anderson P.N., Barker S.E., Duran Y., Bartholomae C., von Kalle C., Heckenlively J.R., Kinnon C., Ali R.R., Thrasher A.J. Effective gene therapy with nonintegrating lentiviral vectors. Nat. Med. 2006, 12:348-353.
63. Zheng, Z.M., Baker, C.C., 2006.Papillomavirus genome structure, expression, and post-transcriptional regulation. Front.Biosci.11, 2286-2302.
64. Zheng Z.M., Baker C.C. Papillomavirus genome structure, expression, and post-transcriptional regulation. Front. Biosci. 2006, 11:2286-2302.
65. Zhou, J., Peng, C., Li, B., Wang, F., Zhou, C., Hong, D., Ye, F., Cheng, X., Lü, W., Xie, X., 2012. Transcriptional gene silencing of HPV16 E6/E7 induces growth inhibition via apoptosis in vitro and invivo.Gynecol.Oncol.124, 296-302.
66. Zhou J., Peng C., Li B., Wang F., Zhou C., Hong D., Ye F., Cheng X., Lü W., Xie X. Transcriptional gene silencing of HPV16 E6/E7 induces growth inhibition via apoptosis in vitro and in vivo. Gynecol. Oncol. 2012, 124:296-302.
67. zur Hausen, H., 2000.Papillomaviruses causing cancer:evasion from host-cell control in early events incarcinogenesis.In:Natl.Cancer Inst.92, 690-698.
68. Zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. Natl. Cancer Inst. 2000, 92:690-698.